Your browser doesn't support javascript.
loading
Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism.
Shi, Jian; Xiao, Jingcheng; Wang, Xinwen; Jung, Sun Min; Bleske, Barry E; Markowitz, John S; Patrick, Kennerly S; Zhu, Hao-Jie.
Afiliação
  • Shi J; Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
  • Xiao J; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.
  • Wang X; Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
  • Jung SM; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.
  • Bleske BE; Department of Pharmacy Practice and Administrative Sciences, The University of New Mexico, Albuquerque, New Mexico, USA.
  • Markowitz JS; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida, USA.
  • Patrick KS; Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Zhu HJ; Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Clin Pharmacol Ther ; 111(4): 878-885, 2022 04.
Article em En | MEDLINE | ID: mdl-34743324

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carboxilesterase / Metilfenidato Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carboxilesterase / Metilfenidato Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article